Upgrade to SI Premium - Free Trial

Neurocrine Biosciences (NBIX) Tops Q2 EPS by 43c, Revenues Beat

July 29, 2019 4:54 PM
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of $0.54, $0.43 better than the analyst estimate of $0.11. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Management Comments

Next Articles